Difference between revisions of "Tyrosine kinase inhibitors"
Jump to navigation
Jump to search
(create) |
(No difference)
|
Revision as of 16:13, 29 March 2012
Tyrosine kinase inhibitors, abbreviated TKIs, are a group of drugs that inhibit the action of tyrosine kinases.
The category includes many cancer drugs - including:
- Imatinib (Gleevec).
- Gefitinib (Iressa).
- Erlotinib (Tarceva).